Streptococcal Submandibular Cellulitis in Young Infants

PEDIATRICS ◽  
1981 ◽  
Vol 67 (3) ◽  
pp. 378-380 ◽  
Author(s):  
Pisespong Patamasucon ◽  
Jane D. Siegel ◽  
George H. McCracken
Keyword(s):  
Clinical Presentation ◽  
Streptococcal Infection ◽  
Group A Streptococcus ◽  
Hemolytic Streptococcus ◽  
Young Infants ◽  
Group A ◽  
Ludwig’S Angina ◽  
Group B ◽  
Ludwig's Angina

Six infants with streptococcal submandibular cellulitis and bacteremia were managed in our institution during a seven-month period. Five uncomplicated cases were caused by group B β-hemolytic Streptococcus, and one rapidly progressive case of Ludwig's angina was caused by group A Streptococcus. Recognition of this characteristic clinical presentation of group B streptococcal infection may be beneficial in the management of such patients.

scholarly journals Ludwig’s angina – evaluation of its medical treatment in 47 cases

2012 ◽  
Vol 7 (3) ◽  
pp. 1-15
Author(s):  
V Sharma
Keyword(s):  
Retrospective Study ◽  
Medical Treatment ◽  
Treatment Efficacy ◽  
Penicillin G ◽  
Medical Sciences ◽  
Intravenous Antibiotic ◽  
Group A ◽  
Ludwig’S Angina ◽  
Group B ◽  
Ludwig's Angina

This is a retrospective study of 47 cases suffering from Ludwig’s angina who received treatment at Manipal Teaching Hospital, Pokhara, between March 2005 and December 2010. Objective of this study was to compare the treatment efficacy of two intravenous antibiotic regimens for the treatment of Ludwig’s angina.27 cases who received crystalline Penicillin G +Metronidazole were placed in group A, while 20 patients who received Ceftriaxone + Clindamycin were placed in group B. The efficacy results based on the disease progressing to abscess formation were analyzed. Journal of College of Medical Sciences-Nepal, 2011, Vol-7, No-3, 1-5 DOI: http://dx.doi.org/10.3126/jcmsn.v7i3.6689 

Group A β-Hemolytic Streptococcal Balanitis: It May Be More Common Than You Think

PEDIATRICS ◽  
1991 ◽  
Vol 88 (1) ◽  
pp. 154-156
Author(s):  
NICHOLAS C. KYRIAZI ◽  
CYNTHIA L. COSTENBADER
Keyword(s):  
Sexual Abuse ◽  
Streptococcal Infection ◽  
Hemolytic Streptococcus ◽  
Depth Study ◽  
Group A

Group A β-hemolytic Streptococcus can cause balanitis in prepubertal males, and its incidence is probably greater than previously reported in the pediatric literature. We suggest the routine inclusion of a GABHS-selective culture in any case where a discharge or irritation is present on the glans or foreskin, especially if a recent streptococcal infection has been documented, whether on not sexual abuse is being considered. Finally, we hope to stimulate interest for further in-depth study of balanitis caused by GABHS.

COMMENTS ON DR. KLEIN'S PAPER

PEDIATRICS ◽  
1973 ◽  
Vol 51 (2) ◽  
pp. 390-390
Keyword(s):  
Air Force ◽  
Streptococcal Infection ◽  
Staphylococcal Infection ◽  
Klein Group ◽  
Significant Difference ◽  
Group A ◽  
Air Force Base ◽  
Group B ◽  
Antibiotic Ointment ◽  
Boston Hospital

Dr. Ribble: In this study was the umbilicus included in bathing of the "diaper area"? Dr. Klein: Yes. Dr. Ribble: Have epidemics of streptococcal disease occured in nurseries in which hexachlorophene bathing was being carried out? Dr. Klein: Group B beta hemolytic streptococcal infections have been reported in nurseries where hexachlorophene bathing was being used. Dr. Schaberg: We have had cultural evidence of the presence of Group A streptococcal infection in infants on hexachlorophene bathing, and another Boston hospital had a nursery epidemic of Group A streptococcal infection in 1967 while using hexachlorophene bathing. Dr. Gezon: Mortimer also reported an epidemic occurring in a nursery where only the babies' faces were washed with hexachlorophene. Leadbetter's data from Lackland Air Force Base showed that he was unable to stop an epidemic of staphylococcal infection with intensive hexachlorophene bathing, including washing the umbilicus three times a day with hexachlorophene. He was also unable to get a significant difference in colonization rates when half the infants were washed with hexachlorophene and half were not. Dr. Gezon: Attention to the umbilicus is very important in controlling staphylococcal infection in the newborn. Jellard has shown this with triple dye, Gillespie with hexachlorophene powder, and Mortimer with antibiotic ointment applied to the umbilicus.

scholarly journals Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections

PLoS ONE ◽  
2019 ◽  
Vol 14 (3) ◽  
pp. e0211786 ◽  
Author(s):  
Yoshihiro Fujiya ◽  
Kayoko Hayakawa ◽  
Yoshiaki Gu ◽  
Kei Yamamoto ◽  
Momoko Mawatari ◽  
...  
Keyword(s):  
Clinical Characteristics ◽  
Streptococcal Infection ◽  
Streptococcal Infections ◽  
Invasive Group ◽  
Age Related ◽  
Group A ◽  
Group B

scholarly journals The Effectiveness of Taalishadi Churna Compared with Sitopaladi Churna in the Management of Kasa

2021 ◽  
pp. 463-470
Author(s):  
Sirjana Shrestha ◽  
Shankar Gautam ◽  
Sabbu Thasineku ◽  
Jitendra Shrestha ◽  
D.L. Bharkher ◽  
...  
Keyword(s):  
Neutrophil Count ◽  
Clinical Presentation ◽  
Treatment Time ◽  
Blood Parameters ◽  
The Other ◽  
Health Statistics ◽  
Group A ◽  
Pre Treatment ◽  
Group B ◽  
Lottery System

Introduction: Kasa is a Vata-kapha pradhana disease, caused due to Vata vimargagaman and Pranavaha shrotodusti. Due to the various similarities in its clinical presentation, Kasa can be correlated with cough (bronchitis). According to National center for health statistics, 62 million cases of common cold and cough occurs each year. Methodology: A total of 44 patients diagnosed as Kasa were randomly divided as per the lottery system of randomization. The patients of Group A were given 5 gram of Sitopaladi Churna twice a day for 30 days. The patients of Group B were given 5 gram of Taalishadi Churna twice a day for 30 days. The patients of both the groups were supposed to follow the dietary and behavioural advices. The response of the drug was assessed at pre-treatment and post-treatment time. Results: There was equal significant change in all of the Roga bala, Agni bala and Deha bala parameters by both Sitopaladi and Taalishadi Churna. It was revealed that all other blood parameters except Hb, TLC and Neutrophil count used in the study were not significant in both the groups. Both drugs were found equally highly significant (p< 0.0001) in Sushka kasa and Swarabheda. Sitopaladi churna was more effective in relieving Hritparswashool (p=0.002) whereas Taalishadi churna is more effective in reducing Pitanisthivanam (p=0.007). In case of Nirghosh, Sitopaladi churna was more effective (p<0.0001). On the other hand, Taalishadi churna was more effective in relieving Peenasa (p<0.001). Conclusion: Both Sitopaladi Churna and Taalishadi Churna were found to be equally effective in the treatment of Kasa.

scholarly journals Study of the Efficacy of Ksharaplota in Dushtavrana w.s.r to Infected Wound

2020 ◽  
Vol 11 (2) ◽  
pp. 314-321
Author(s):  
Anantkumar V Shekokar ◽  
Vijay P Ukhalkar
Keyword(s):  
Clinical Presentation ◽  
Healing Time ◽  
Control Group ◽  
Infected Wound ◽  
Group Assessment ◽  
Before And After ◽  
Group A ◽  
Level Of Significance ◽  
Group B ◽  
Vast Range

Vrana ( wound and ulcer) & process of healing is the soul of Shalyatantra Chikitsa (Surgical treatment ). Dushta Vrana means getting vitiated by Dosha & hence Dushta Vrana or infected wound is characterized by bad smell, abnormal color with profuse discharge, severe pain and longer healing time. The severity of infected wounds and their vast range of etiologies, The treatment is cleaning & dressing the wound or it can be more extensive. It may require surgical intervention to close the wound and stabilize the patient. Acharya Sushruta defines Kshara as the substance possessing Ksharana and Kshanan properties. Ksharaplota formulation was selected and applied over the affected infected wound with the help of gauze piece. During the preparation of Ksharaplota, it is coated with Snuhi kshira, Apamarga kshara & Haridra. All these drugs are Shodhana & Ropana. It was observed that Ksharaplota has the properties as sustained release of drug, absorbs discharges, less painful & easily acceptable by the patient with excellent Sodhana & Ropana Karma. The clinical study has been done on 438 patients, selected randomly and divided in two groups. Group A 220 patients i.e. trial group, were treated with local application of Ksharaplota. The Group B 218 patients i.e. control group, were treated with Gold standard. The clinical assessment was done on the basis of clinical presentation of Dushta Vrana, (Infected wound) before and after the treatment. As grading used for assessment of parameters which were ordinal in nature, “Wilcoxon Signed Ranks test” was used for within the group assessment (i.e. before and after treatment of a group). For between the group assessment of parameters, Mann Whitney – U test was applied. We had tested hypothesis for each parameter and result was interpreted accordingly. The level of significance was kept at 5% (P=0.05). And the result of the present study found significant.

Poststreptococcal Movement Disorders

2017 ◽  
Author(s):  
Davide Martino ◽  
Gavin Giovannoni
Keyword(s):  
Movement Disorders ◽  
Streptococcal Infection ◽  
Group A Streptococcus ◽  
Neuropsychiatric Symptoms ◽  
Causal Link ◽  
Obsessive Compulsive ◽  
Behavioral Abnormalities ◽  
Group A ◽  
Obsessive Compulsive Disorders ◽  
Compulsive Disorders

The spectrum of “poststreptococcal” movement disorders and other behavioral abnormalities has expaanded and the array of neuropsychiatric features associated with rheumatic fever (RF) has been broadened. However, it is difficult to establish a causal link between Group A Streptococcus (GAS) and neuropsychiatric symptoms beyond RF, which has fuelled a long-lasting, and still unsolved, debate as to whether putative “poststreptococcal” disorders such as the PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection) phenotype are distinct entities or not. This chapter provides an up-to-date overview of the conditions that are well established (Sydenham’s chorea) or proposed (poststreptococcal tic and obsessive-compulsive disorders) as secondary to an immune response toward GAS.

scholarly journals Transcatheter and intraoperative device closure of atrial septal defect in infants under three years of age

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Yangyang Han ◽  
Xiquan Zhang ◽  
Fengwei Zhang
Keyword(s):  
Atrial Septal Defect ◽  
Hospital Stay ◽  
Clinical Data ◽  
Septal Defect ◽  
Postoperative Hospital Stay ◽  
Device Closure ◽  
Young Infants ◽  
Group A ◽  
Group B

Abstract Background Transcatheter and intraoperative device closures have been widely used in the treatment of secundum atrial septal defect (ASD). However, for young infants with ASD, device closure remains controversial, and such treatment features limited data. We compared the clinical data and follow-up results of percutaneous and intraoperative device closure for ASD to evaluate the feasibility, safety, and efficacy of both treatments in infants under 3 years of age. Methods From September 2010 to September 2018, 186 children under 3 years of age with significant secundum ASD were included in this study. A total of 88 and 98 patients were divided into groups A (transcatheter device closure) and B (intraoperative device closure), respectively. The clinical data and follow-up results of the two groups were analyzed retrospectively. Result The mean age and weight of patients in group A were significantly higher than those in group B. The proportion of complex ASDs (multiples or rims deficiency) and the device/weight ratio in group B were significantly higher than those in group A. Successful closure was obtained in 86 (97.7%) and 96 (98.0%) infants in groups A and B, respectively, with two failed cases in each group (2.3% vs 2%). The rate of periprocedural complications reached 13.6 and 26.5% for groups A and B (P = 0.058), respectively. The durations of the procedure and postoperative hospital stay in group A were significantly shorter than those in group B (P < 0.05). Excellent follow-up results were observed in both groups. At present, no death nor major complications have occurred. Symptoms either resolved completely or improved significantly for all symptomatic infants. No residual shunts at the 6th month of follow-up evaluation were observed. Patients with failure to thrive gained weight appropriately for age, and the structure and hemodynamic parameters significantly improved during follow-up. Conclusion Transcatheter and intraoperative device closure are feasible, effective, and safe methods for the treatment of ASDs in infants under 3 years of age. Considering improved cosmetic effect and the short duration of the procedure and postoperative hospital stay, transcatheter is preferred for patients with appropriate conditions. Intraoperative device closure can be performed as an alternative to percutaneous closure, particularly for infants with large, complex ASDs, young age, or low-body weight.

Sign in / Sign up

Export Citation Format

Share Document